Abstract Body

HPV is accepted today as the necessary but not sufficient etiological agent for anal and cervical neoplasia and HIV appears to be a cofactor in the association between HPV and cervical neoplasia. The objective of our study is the identification of a distinct transcriptomic signature that may serve as predictive markers of dysplasia and/or malignancy in HIV+/+HPV patients.

The study includes a unique cohort of 25 HIV-1 infected individuals co-infected with HPV with a clinical follow-up for more than 20 years. Tissue samples from individuals with signs of a high degree of anal dysplasia were chirurgical collected, together with samples from normal tissue from the same individual as control. After RNA extraction and quality control, RNA library was constructed (Illumina TruSeq RNA stranded) and sequencing was performed (Novaseq, 30M reads/sample). Data analysis was performed as implemented in the computational workflow for the detection of differentially expressed genes and pathways from RNA-seq data. Read alignment and count quantification was conducted using the Rsubread package and the statistical analysis was performed using the edgeR package. The differential expression analysis uses the quasi-likelihood functionality of edgeR.

Whole transcriptome sequencing was performed to examine differential gene expression profiles, and to perform gene annotation based on gene ontology pathway information. Analyses were successfully performed on all 25 paired-ends samples with overall read mapping ratio above 95%. Thirty genes showed significant changes between biopsies showing a high degree of dysplasia and apparently healthy control biopsies. Hierarchic clustering of data demonstrated a clear discrimination between healthy and dysplasic tissues, indicating a common pattern of gene expression changes between individuals. The identified differentially expressed genes include chemokines, potential restriction factors, a miRNA and genes associated to cell proliferation and cell transformation. After filtering the results based on functionality, we selected for further validation a group of 15 genes that fulfill the criteria for becoming a biomarker.

Our analysis allowed the identification of at least 15 potential predictive markers of anal dysplasia in co-infected HIV/HPV individuals. Characterization of the selected genes may result in the development of new therapeutic approaches to treat HIV/HPV induced malignancies.